Zalcitabine Pages on BioPortfolio:

BioPortfolio - Zalcitabine
Zalcitabine - BioPortfolio - Indepth. ... BioPortfolio Ltd. offers e-mail and postal lists for Zalcitabine scientists - we have details of around 129 ...
http://www.bioportfolio.com/indepth/Zalcitabine.html...

BioPortfolio.com - BioWeb TAXOTERE DOCETAXEL genentechidec ...
... Approval Date AP Time Approval Basis Indication - - - - - - - - 20199 Hivid Zalcitabine 31-Oct-91 19-Jun-92 7.6 S Combination therapy with zidovudine in ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?DB=se...

BioPortfolio - Zalcitabine
Click here to return to the Zalcitabine main in depth entry. ... Zalcitabine , also called dideoxycytidine, is a nucleoside analog reverse transcriptase ...
http://www.bioportfolio.com/search/Zalcitabine.html...

BioPortfolio's Approved Drugs News by Tradename - H
HIVID+ZALCITABINE · HMS+MEDRYSONE · HUMALOG+INSULIN+LISPRO+RECOMBINANT · HUMATIN +PAROMOMYCIN+SULFATE · HUMATROPE+SOMATROPIN+RECOMBINANT ...
http://www.bioportfolio.co.uk/approved_drugs/approved_drug_p...

BioPortfolio - Zalcitabine research
Recent Publications on Zalcitabine:. Neurologic disorders are prevalent in HIV- positive outpatients in the Asia-Pacific region. ...
http://www.bioportfolio.com/indepth/Zalcitabine/research.htm...

BioPortfolio - Zalcitabine patents
«Zalcitabine. Below is an extended Zalcitabine patents listing. Click here to return to the Zalcitabine main in depth entry. ...
http://www.bioportfolio.com/indepth/Zalcitabine/patents.html...

BioPortfolio - Zalcitabine - InDepth
View the current Zalcitabine InDepth page on BioPortfolio.com ... Zalcitabine , also called dideoxycytidine, is a nucleoside analog reverse transcriptase ...
http://www.bioportfolio.com/indepth/Zalcitabine.pdf...

BioPortfolio - ppk
The paucity of pharmacokinetic (PK) data for zalcitabine (ddC) at doses < or = 0.75 mg prompted ... Prospective evaluation of zalcitabine (ddC) population .
...
http://www.bioportfolio.com/search/ppk.html...

BioPortfolio - DDC
The paucity of pharmacokinetic (PK) data for zalcitabine (ddC) at doses < or = 0.75 mg prompted a PPK evaluation of ddC in our HIV population. ...
http://www.bioportfolio.com/search/DDC.html...

BioPortfolio - Zygote
Pronunciations: zalcitabine - zygote intrafallopian tube transfer ... zalcitabine · Zenker's diverticulum · zidovudine · zygote intrafallopian tube
transfer ...
http://www.bioportfolio.com/search/Zygote.html...

Results from other life science and pharmaceutical sites:

AIDS Drug Zalcitabine (ddC)
Zalcitabine was approved for use in combination with the first approved AIDS drug, zidovudine -- or AZT -- as a treatment option for adult patients with ...
http://www.fda.gov/bbs/topics/NEWS/NEW00283.html...

Pronunciations: zalcitabine - zygote intrafallopian tube transfer ...
zalcitabine · Zenker's diverticulum · zidovudine · zygote intrafallopian tube transfer ...
http://www.merck.com/mmhe/resources/pronunciations/index/z.h...

Ask the Experts - Is Zidovudine/Zalcitabine Still Used?
Is the combination of zidovudine and zalcitabine still used or recommended as part of antiretroviral therapy? In recent guidelines other combinations appear
...
http://www.medscape.com/viewarticle/412442...

Zalcitabine: Drug Information Provided by Lexi-Comp: Merck Manual ...
In combination with at least two other antiretrovirals in the treatment of patients with HIV infection; it is not recommended that zalcitabine be given in
...
http://www.merck.com/mmpe/lexicomp/zalcitabine.html...

Prospective evaluation of zalcitabine (ddC) population ...
The paucity of pharmacokinetic (PK) data for zalcitabine (ddC) at doses < or = 0.75 mg prompted a PPK evaluation of ddC in our HIV population. ...
http://gateway.nlm.nih.gov/MeetingAbstracts/102205211.html...

Zalcitabine. An update of its pharmacodynamic and ...[Drugs. 1997 ...
PubMed is a service of the US National Library of Medicine that includes over 18 million citations from MEDLINE and other life science journals for ...
http://www.ncbi.nlm.nih.gov/pubmed/9179531?dopt=Abstract...

Zalcitabine (ddC) in combination with zidovudine (ZDV,AZT) for ...
OBJECTIVE: To evaluate the safety, tolerance and efficacy of zalcitabine (2.25 mg/d) plus ZDV (600 mg/d) in patients with advanced HIV-infection with CD4 ...
http://gateway.nlm.nih.gov/MeetingAbstracts/102208561.html...

Pharmacokinetics of saquinavir, zidovudine, and zalcitabine in ...
We investigated the pharmacokinetics of zidovudine, zalcitabine, and saquinavir in AIDS Clinical Trial Group protocol 229. ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=16...

Antiviral activity and safety of twice daily zalcitabine in ...
This study compares the antiviral activity and safety of zalcitabine BID + zidovudine (ZDV) + a protease inhibitor (PI) to that of 3TC + ZDV + PI in ...
http://gateway.nlm.nih.gov/MeetingAbstracts/102239125.html...

Home Marketing Services News Reports Company Profiles InDepth Drug Discovery Careers Conferences Videos Search Contact
	Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner. See User Agreement Send comments and feedback to: Peter Barfoot Managing Director, BioPortfolio Ltd. UK Tel: (+44) 1300 321501 USA Voicemail and Fax: (+1) 415 680 2472	All rights reserved. All other trademarks recognized. BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10 Copyright 1997-2008 - BioPortfolio Limited.